Developing new methods to create targeted therapies for Alzheimer's disease
Official title: Engineering and application of modular chimeric tRNA synthetases in mRNA display
Funded at Univ of North Carolina Chapel Hill · NIH-11071528 · Data updated 2026-11-12
This study is exploring new ways to create special treatments for Alzheimer's disease that can better target the proteins causing the condition, with the hope of offering patients more effective options to slow down its progression or ease symptoms.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project start | December 1, 2024 |
| Project end | November 30, 2027 |
| Funding year | 2025 |
| Award (this year) | $73,828 |
| NIH project number | 1F32GM157944-01 |
| Project ID | NIH-11071528 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those at risk of developing it.
✕Less likely to help
Patients with other forms of dementia unrelated to Alzheimer's may not receive benefit from this research.
What this research studies
This research focuses on engineering modular chimeric tRNA synthetases to enhance the development of macrocyclic peptide therapeutics (MPTs) that can effectively target proteins involved in Alzheimer's disease. By utilizing advanced techniques to incorporate non-canonical amino acids into peptides, the research aims to improve the specificity and binding affinity of these therapeutics. Patients may benefit from new treatment options that can more effectively disrupt the processes leading to Alzheimer's disease, potentially slowing its progression or alleviating symptoms.
Why it matters
Potential benefit: If successful, this research could lead to more effective therapies for Alzheimer's disease, improving patient outcomes.
How similar studies have gone: Previous research has shown promise in using similar approaches to target difficult proteins, indicating potential for success in this area.
Where this research is happening
-
Univ of North Carolina Chapel Hill
Chapel Hill, United States Active
Researchers
- Principal investigator: Ellis, Jonathan M — Univ of North Carolina Chapel Hill
- Study coordinator: Ellis, Jonathan M
Related research
Other NIH-funded projects on the same topics.
-
A center for coordinating data related to heart and blood health.
This study is working on a new system to gather and analyze health information about heart and blood disorders, which could lead to better ways to diagnose and treat these conditions, ultimately helping patients like you.
-
Healthy work design and worker well-being
A multi-site program aims to improve the health and well-being of workers by studying how work design affects safety, stress, and quality of life.
-
Unified and fair multimodal learning for autoimmune diseases
A patient-friendly AI approach will combine many kinds of health data to improve diagnosis and personalized care for autoimmune diseases, including lupus.
-
Structural factors linking minimum wage, COVID-19, and community violence
A long-term study will explore whether higher minimum wages and pandemic-related economic factors are connected to changes in violence in US communities.
-
Non-invasive tears biomarker for early Alzheimer's in LMICs
A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.
-
How HPV interacts with our cells' DNA damage system and its effect on cancer
This project looks at how high-risk HPV uses the body’s DNA repair machinery to replicate and potentially drive cancer, with the goal of finding new antiviral and cancer-fighting approaches for people affected by HPV-related diseases.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.